首页> 美国卫生研究院文献>BMJ Open Access >Audit research and guideline update: Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (The BeLieVeR-HIFi trial): study design and rationale
【2h】

Audit research and guideline update: Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (The BeLieVeR-HIFi trial): study design and rationale

机译:审计研究和指南更新:支气管镜下支气管内瓣膜缩小术治疗异性气肿和完整叶间裂的患者(BeLieVeR-HIFi试验):研究设计和原理

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although lung volume reduction surgery improves survival in selected patients with emphysema, there has been ongoing interest in developing and evaluating bronchoscopic approaches to try to reduce lung volumes with less morbidity and mortality. The placement of endobronchial valves is one such technique, and although some patients have had a significant improvement, responses have been inconsistent because collateral ventilation prevents lobar atelectasis. We describe the protocol of a trial (ISRCTN04761234) aimed to show that a responder phenotype, patients with heterogeneous emphysema and intact interlobar fissures on CT scanning, can be identified prospectively, leading to a consistent benefit in clinical practice.
机译:尽管肺减容术可以改善某些肺气肿患者的生存率,但人们一直对开发和评估支气管镜检查方法以降低发病率和死亡率的肺活量感兴趣。支气管内瓣膜的放置就是这样一种技术,尽管有些患者已有明显改善,但由于侧支通气可防止肺叶肺不张,因此反应不一致。我们描述了一项试验协议(ISRCTN04761234),旨在表明可以前瞻性地确定应答者表型,异质性气肿和CT扫描时叶间裂完整的患者,从而在临床实践中产生一致的益处。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号